🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 4 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/05/2025 | 100,18 | 101,64 | 99,12 | 100,91 | +0,72% | 2,52% | 124.700 |
| 28/05/2025 | 101,60 | 101,60 | 98,90 | 100,19 | -1,43% | 2,66% | 114.200 |
| 27/05/2025 | 103,11 | 103,17 | 100,99 | 101,64 | +0,04% | 2,11% | 122.800 |
| 23/05/2025 | 100,01 | 102,11 | 99,29 | 101,60 | +0,31% | 2,82% | 107.100 |
| 22/05/2025 | 102,10 | 102,73 | 101,03 | 101,29 | -1,13% | 1,67% | 76.700 |
| 21/05/2025 | 103,75 | 104,58 | 101,40 | 102,45 | -2,35% | 3,07% | 84.600 |
| 20/05/2025 | 105,36 | 105,36 | 102,78 | 104,92 | -0,37% | 2,45% | 108.900 |
| 19/05/2025 | 104,00 | 105,42 | 101,84 | 105,31 | +0,74% | 3,44% | 95.400 |
| 16/05/2025 | 103,00 | 105,19 | 103,00 | 104,54 | +1,03% | 2,13% | 79.600 |
| 15/05/2025 | 104,68 | 105,40 | 102,69 | 103,47 | -1,54% | 2,59% | 83.800 |
| 14/05/2025 | 107,51 | 108,45 | 104,50 | 105,09 | -0,51% | 3,67% | 164.800 |
| 13/05/2025 | 106,38 | 107,81 | 104,55 | 105,63 | -0,71% | 3,06% | 136.100 |
| 12/05/2025 | 107,54 | 109,20 | 104,65 | 106,38 | +1,82% | 4,23% | 141.300 |
| 09/05/2025 | 102,08 | 107,15 | 102,08 | 104,48 | +1,92% | 4,97% | 148.600 |
| 08/05/2025 | 106,92 | 107,37 | 99,24 | 102,51 | -2,94% | 7,60% | 170.000 |
| 07/05/2025 | 104,90 | 106,32 | 103,36 | 105,62 | +2,23% | 2,82% | 146.600 |
| 06/05/2025 | 105,25 | 106,81 | 102,50 | 103,32 | -2,85% | 4,10% | 95.800 |
| 05/05/2025 | 109,20 | 109,20 | 104,99 | 106,35 | -2,78% | 3,86% | 120.500 |
| 02/05/2025 | 110,85 | 111,42 | 108,50 | 109,39 | +0,22% | 2,63% | 81.100 |
| 01/05/2025 | 110,67 | 110,74 | 107,86 | 109,15 | -0,65% | 2,60% | 77.700 |
| 30/04/2025 | 110,71 | 111,48 | 107,34 | 109,86 | -1,36% | 3,74% | 105.800 |
| 29/04/2025 | 108,69 | 112,55 | 108,69 | 111,38 | +2,30% | 3,55% | 83.900 |
| 28/04/2025 | 108,04 | 109,31 | 106,96 | 108,88 | +0,75% | 2,18% | 84.600 |
| 25/04/2025 | 106,95 | 108,34 | 104,65 | 108,07 | -0,44% | 3,45% | 102.800 |
| 24/04/2025 | 105,93 | 109,24 | 104,97 | 108,55 | +2,64% | 4,03% | 80.500 |
| 23/04/2025 | 109,51 | 111,39 | 105,62 | 105,76 | -0,67% | 5,27% | 171.400 |
| 22/04/2025 | 106,73 | 107,51 | 105,35 | 106,47 | +1,58% | 2,02% | 102.700 |
| 21/04/2025 | 103,98 | 105,42 | 102,95 | 104,81 | -0,15% | 2,38% | 88.500 |
| 17/04/2025 | 104,24 | 106,00 | 101,24 | 104,97 | +0,33% | 4,57% | 105.100 |
| 16/04/2025 | 106,59 | 106,59 | 102,64 | 104,62 | -2,04% | 3,71% | 77.700 |